J. Hegmans

J. Aerts, J. Hegmans, K. Bezemer, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Extended Tumor Control after Dendritic Cell Vaccination with Low Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma at a Glance Commentary

H. Hoogsteden, J. Aerts, R. Hendriks, 2022 .

OA13.06 Autologous Dendritic Cells Loaded with Allogeneic Tumor Cell Lysate (Pheralys®) in Patients with Mesothelioma: Final Results of a Phase I Study

H. Hoogsteden, J. Aerts, R. Hendriks, 2017 .

Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.

J. Aerts, J. Hegmans, K. Bezemer, 2017, Lung cancer.

Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy

J. Aerts, R. Hendriks, J. Hegmans, 2017, Cancer Immunology Research.

TCRGene Transfer : MAGE-C 2 / HLA-A 2 andMAGE-A 3 / HLA-DP 4 Epitopes as Melanoma-Specific Immune Targets

B. Lambrecht, M. Broertjes, P. Coulie, 2012 .

TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets

B. Lambrecht, M. Broertjes, P. Coulie, 2012, Clinical & developmental immunology.

Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer

H. Groen, H. Hoogsteden, E. Smit, 2015, Oncoimmunology.

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.

H. Groen, F. Muskens, H. Hoogsteden, 2013, Lung cancer.

Biomarkers for immune checkpoint inhibitors.

J. Aerts, J. Hegmans, L. Lievense, 2014, The Lancet. Oncology.

Dendritic cell-based immunotherapy in

H. Hoogsteden, J. Aerts, R. Hendriks, 2012 .

Dendritic cell-based immunotherapy in mesothelioma.

H. Hoogsteden, J. Aerts, R. Hendriks, 2012, Immunotherapy.

Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer.

J. Aerts, J. Hegmans, 2013, Cancer research.

Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.

H. Janssen, A. Woltman, J. Hegmans, 2011, Journal of hepatology.

Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer.

E. Smit, J. Aerts, S. Senan, 2017, American journal of respiratory and critical care medicine.

Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma.

H. Hoogsteden, J. Aerts, R. Hendriks, 2015, Lung cancer.

Mesothelioma environment comprises cytokines and Treg cells that suppress immune responses

H. Hammad, B. Lambrecht, L. Boon, 2006 .

New Roads Open Up for Implementing Immunotherapy in Mesothelioma

H. Hoogsteden, J. Aerts, R. Hendriks, 2012, Clinical & developmental immunology.

Increased expression of interleukin-4 receptors on psoriatic epidermal cells.

R. Benner, E. Prens, R. Debets, 1996, The American journal of pathology.

Expression of cytokines and their receptors by psoriatic fibroblast. I. Altered IL-6 synthesis.

R. Benner, E. Prens, M. Deleuran, 1996, Cytokine.

with bronchial hyperresponsiveness Effects of fluticasone propionate in COPD patients

H. Hoogsteden, J. Bogaard, J. Hegmans, 2006 .

Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness

H. Hoogsteden, J. Bogaard, J. Hegmans, 2002, Thorax.

methacholine dose-response curves in atopic asthma Eosinophils in the bronchial mucosa in relation to

H. Hoogsteden, J. Bogaard, J. Hegmans, 2006 .

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

J. Aerts, J. Hegmans, N. M. Mahaweni, 2013, Journal of extracellular vesicles.

Effects of cyclosporine on cytokines and cytokine receptors in psoriasis.

R. Benner, E. Prens, J. Hegmans, 1995, Journal of the American Academy of Dermatology.

A model system for optimising the selection of membrane antigen-specific human antibodies on intact cells using phage antibody display technology.

J. Prins, K. Radošević, J. Hegmans, 2002, Journal of immunological methods.

Proteomic analysis of exosomes isolated from human malignant pleural effusions.

Bart N Lambrecht, Rob Willemsen, Theo M Luider, 2004, American journal of respiratory cell and molecular biology.

Proteomic analysis of exosomes secreted by human mesothelioma cells.

H. Hoogsteden, B. Lambrecht, L. Zitvogel, 2004, The American journal of pathology.

Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release.

R. Benner, E. Prens, R. Debets, 1995, European journal of immunology.

Advances in diagnosis and treatment of malignant mesothelioma

J. Hegmans, 2006 .

Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human

H. Hoogsteden, J. Aerts, B. van der Holt, 2017, Clinical Cancer Research.

Immunotherapy prospects in the treatment of lung cancer and mesothelioma.

H. Hoogsteden, J. Aerts, J. Hegmans, 2014, Translational lung cancer research.

Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses

H. Hammad, H. Hoogsteden, B. Lambrecht, 2006, European Respiratory Journal.

Tumor-associated macrophages in thoracic malignancies.

J. Aerts, J. Hegmans, K. Bezemer, 2013, Lung cancer.

History of tuberculosis as an independent prognostic factor for lung cancer survival.

A. Hofman, A. Uitterlinden, R. V. van Klaveren, 2012, Lung cancer.

Immuno-Oncology and Immunotherapy

J. Aerts, J. Hegmans, R. Cornelissen, 2012 .

Improving lung cancer survival; time to move on

Bruno H Stricker, B. Stricker, J. Aerts, 2012, BMC Pulmonary Medicine.

Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

H. Hoogsteden, J. Aerts, L. Arends, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Ef fi cacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small Cell Lung Cancer : A Systematic Review and Meta-Analysis

H. Hoogsteden, J. Aerts, L. Arends, 2016 .

Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.

Bart N Lambrecht, H. Hoogsteden, B. Lambrecht, 2005, American journal of respiratory and critical care medicine.

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment

H. Groen, H. Hoogsteden, J. Aerts, 2012, BMC Cancer.

Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression.

W A Buurman, W. Buurman, R. Benner, 1996, Cytokine.

Personalized Immune Therapy

J. Aerts, J. Hegmans, L. Lievense, 2017 .

[Exosomes and cancer].

M. Lamfers, C. Dirven, J. Hegmans, 2011, Nederlands tijdschrift voor geneeskunde.

Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles

B. Stricker, J. Aerts, J. Hou, 2019, BMC Cancer.

Expression Profiling-Based Subtyping Identifies Novel Non-small Cell Lung Cancer Subgroups and Implicates Putative Resistance to Pemetrexed Therapy

H. Hoogsteden, F. Grosveld, J. Aerts, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.

J. Prins, R. Benner, E. Prens, 1997, Journal of immunology.

HIF1a expression in bronchial biopsies correlates with tumor microvascular saturation determined using optical spectroscopy.

H. Hoogsteden, J. Aerts, A. Amelink, 2007, Lung cancer.

Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles

B. Stricker, J. Aerts, J. Hou, 2019, BMC Cancer.

History of tuberculosis as an independent prognostic factor for lung cancer survival.

R. V. van Klaveren, H. Hoogsteden, B. Stricker, 2012, Lung cancer.

Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.

H. Hoogsteden, J. Hegmans, K. Bezemer, 2016, American journal of respiratory and critical care medicine.

Immune Therapy.

J. Aerts, J. Hegmans, L. Lievense, 2016, Advances in experimental medicine and biology.